Review Note

Last Update: 08/30/2023 12:42 AM

Current Deck: ACMS Study Guide Deck::A. Cancers

Published

Fields:

Front
Pembrolizumab what is it and MOA
Back
Monoclonal IgG4 antibody targeting PD-1 (treats SCC)
▪ Antibody binds to PD-1 receptor and blocks interaction with PD-L1
and PD-L2

Tags:

A.Cancers

Suggested Changes:

Deck Changes (Suggestion to move the Note to the following Deck):

Field Changes:

Tag Changes: